A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Organon & Co. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 55,506 shares of OGN stock, worth $834,255. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,506
Previous 55,506 -0.0%
Holding current value
$834,255
Previous $1.06 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$18.65 - $23.03 $80,157 - $98,982
4,298 Added 8.39%
55,506 $1.06 Million
Q2 2024

Jul 29, 2024

SELL
$17.45 - $21.96 $593 - $746
-34 Reduced 0.07%
51,208 $1.06 Million
Q1 2024

Apr 25, 2024

SELL
$13.78 - $18.8 $67,356 - $91,894
-4,888 Reduced 8.71%
51,242 $963,000
Q4 2023

Jan 30, 2024

BUY
$10.95 - $17.32 $92,987 - $147,081
8,492 Added 17.83%
56,130 $809,000
Q3 2023

Oct 25, 2023

BUY
$16.59 - $23.77 $100,303 - $143,713
6,046 Added 14.54%
47,638 $826,000
Q2 2023

Aug 07, 2023

BUY
$19.27 - $24.63 $70,663 - $90,318
3,667 Added 9.67%
41,592 $865,000
Q1 2023

May 08, 2023

BUY
$21.42 - $32.08 $60,040 - $89,920
2,803 Added 7.98%
37,925 $891,000
Q4 2022

Feb 01, 2023

BUY
$23.31 - $28.61 $75,757 - $92,982
3,250 Added 10.2%
35,122 $981,000
Q3 2022

Nov 09, 2022

SELL
$23.4 - $34.25 $234 - $342
-10 Reduced 0.03%
31,872 $746,000
Q2 2022

Aug 09, 2022

BUY
$31.66 - $38.9 $1.01 Million - $1.24 Million
31,882 New
31,882 $1.08 Million
Q1 2022

Apr 21, 2022

SELL
$30.45 - $39.36 $987,006 - $1.28 Million
-32,414 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$28.67 - $37.13 $138,877 - $179,857
4,844 Added 17.57%
32,414 $987,000
Q3 2021

Nov 15, 2021

BUY
$28.63 - $35.64 $789,329 - $982,594
27,570 New
27,570 $904,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.82B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.